XM does not provide services to residents of the United States of America.

FX options wrap - Euro vols surge again; U.S. CPI risk underpriced



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-FX options wrap - Euro vols surge again; U.S. CPI risk underpriced</title></head><body>

The euro has beenunder broad-based pressure since France announced a snap election, with the benchmark 1-month expiry euro based FX option implied volatility becoming the bellwether for related FX realised volatility and directional risk.

EUR/USD 1-month expiry implied volatility reached 6.6 on Tuesday after initial gains from 5.1 to 6.0 Friday-Monday. Demand came as EUR/USD spot marginally extended Monday's 1.0733 low to fuel more downside short covering.

One-month 25 delta risk reversals extended initial 0.15 -0.55 gains to 0.65 EUR puts over calls on Tuesday - their highest downside strike premium since April.

Other expiry dates saw implied volatility extend gains, too - 3-month EUR/USD paid 5.8 to 6.1 on Tuesday from 5.35 on Friday and 1-year to 6.6 from 6.4. EUR/cross vols also got another boost - EUR/GBP 1-month extended gains from Friday's 3.75 low to 5.35 and 1-month EUR/CHF to 6.4 from 5.2. Contagion spread through other pairings, although their implied volatilities gained to a much lesser extent.

The USD has been on the front foot since Friday's NFP beat and the market is now awaiting Wednesday's U.S. CPI data and Fed policy announcement. Overnight expiry only includes the former until Wednesday itself, but related implied volatility appears woefully underpriced when compared to the additional gains before previous U.S. CPI releases.

Beware huge GBP/USD expiries at 1.2800 if Wednesday's UK data beats and/or U.S. CPI data misses expectations in a boost to GBP/USD. USD/ZAR implied volatility and topside strike premiums are at long term highs and warn of further potential for FX volatility and ZAR losses.




For more click on FXBUZ


1-month expiry FXO implied volatility https://tmsnrt.rs/45hiulX

Overnight expiry FXO implied volatility https://tmsnrt.rs/3RoOKhb

(Richard Pace is a Reuters market analyst. The views expressed are his own)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.